Loading…
Held by equity mutual funds in 38 disclosed months, Aug 2023 to Sep 2026.
Concord Biotech Limited (Pharmaceuticals & Biotechnology) was held by 10 active equity mutual funds in September 2026, ₹741 Cr in all (down 1 fund from Aug 2026). The largest position was DSP Healthcare Fund at 2.7% of its portfolio. During the month 1 fund entered and 2 exited. Funds have disclosed holding it since Aug 2023.
Weight is the share of that fund's portfolio; change is against the previous disclosed month.
How many equity funds held the company each month, and the value they held.